Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes
Public ClinicalTrials.gov record NCT04365400. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomised, Double-Blind, Placebo-Controlled, Dose Finding Phase IIb Study to Assess the Efficacy and Safety of Orally Administered Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To assess the efficacy and safety of orally administered Epeleuton capsules versus placebo, in the treatment of adult patients with hypertriglyceridemia and type 2 diabetes
Study identification
- NCT ID
- NCT04365400
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 233 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 13, 2020 (Actual)
- Primary completion
- May 3, 2022 (Actual)
- Completion
- May 3, 2022 (Actual)
- Last update posted
- Jun 12, 2023
2020 – 2022
United States locations
- U.S. sites
- 32
- U.S. states
- 11
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| US Site 5 | Little Rock | Arkansas | 72204 | — |
| US Site 23 | Cerritos | California | 90703 | — |
| US Site 18 | Huntington Park | California | 90255 | — |
| US Site 19 | Los Angeles | California | 90057 | — |
| US Site 20 | Panorama City | California | 91402 | — |
| US Site 21 | Santa Ana | California | 92704 | — |
| US Site 13 | Santa Ana | California | 92705 | — |
| US Site 15 | Adairsville | Georgia | 30103 | — |
| US Site 35 | Ames | Iowa | 50010 | — |
| US Site 2 | Albany | New York | 12203 | — |
| US Site 25 | Hickory | North Carolina | 28601 | — |
| US Site 11 | Morehead City | North Carolina | 28557 | — |
| US Site 34 | Raleigh | North Carolina | 27609 | — |
| US Site 26 | Rocky Mount | North Carolina | 27804 | — |
| US Site 28 | Salisbury | North Carolina | 28144 | — |
| US Site 32 | Statesville | North Carolina | 28625 | — |
| US Site 27 | Wilmington | North Carolina | 28601 | — |
| US Site 22 | Edmond | Oklahoma | 73013 | — |
| US Site 1 | Wyomissing | Pennsylvania | 19610 | — |
| US Site 3 | Yardley | Pennsylvania | 19067 | — |
| US Site 12 | Jackson | Tennessee | 38301 | — |
| US Site 7 | Dallas | Texas | 75231 | — |
| US Site 8 | Fort Worth | Texas | 76107 | — |
| US Site 14 | Fort Worth | Texas | 76164 | — |
| US Site 24 | Houston | Texas | 77036 | — |
| US Site 30 | Houston | Texas | 77061 | — |
| US Site 6 | Houston | Texas | 77079 | — |
| US Site 33 | Houston | Texas | 77099 | — |
| US Site 29 | Missouri City | Texas | 77459 | — |
| US Site 31 | North Richland Hills | Texas | 76180 | — |
| US Site 10 | Waco | Texas | 76708 | — |
| US Site 17 | Winchester | Virginia | 22601 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04365400, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2023 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04365400 live on ClinicalTrials.gov.